Hu, Z., Hu, Y., Liu, X., Xi, R., Zhang, A., Liu, D., . . . Chen, L. (2018). Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor. Oncotarget.

Hu, Zexi, Yong Hu, Xicheng Liu, Rongwen Xi, Aiqun Zhang, Deruo Liu, Qiang Xie, و Liang Chen. "Correction: Tumor Driven By Gain-of-function HER2 H878Y Mutant Is Highly Sensitive to HER2 Inhibitor." Oncotarget 2018.

Hu, Zexi, et al. "Correction: Tumor Driven By Gain-of-function HER2 H878Y Mutant Is Highly Sensitive to HER2 Inhibitor." Oncotarget 2018.